Intracellular uptake of folate receptor targeted superparamagnetic naoparticles for enhanced tumor detection by MRI

2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings

Volumn , Issue , 2005, Pages 74-77

  Sun, Conroy ^a   Veiseh, Omid ^a   Kohler, Nathan ^a   Gunn, Jonathan ^b   Lee, Donghoon ^c   Sze, Raymond ^d   Hallahan, Andrew ^d   Zhang, Miqin ^a  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Folic acid; Magnetite nanoparticles; MRI; PEG; Tumor imaging

Indexed keywords

FOLIC ACID; MAGNETIC NANOPARTICLES; TUMOR IMAGING;

CELLS; MAGNETIC RESONANCE IMAGING; POLYETHYLENE GLYCOLS; SUPERPARAMAGNETISM; TUMORS;

NANOSTRUCTURED MATERIALS;

EID: 32044474407     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (12)

1. Josephson, L., et al., The Effects of Iron-Oxides on Proton Relaxivity. Magnetic Resonance Imaging, 1988. 6(6): p. 647-653.
2. Majumdar, S., et al., A Quantitative Study of Relaxation Rate Enhancement Produced by Iron-Oxide Particles in Polyacrylamide Gels and Tissue. Magnetic Resonance in Medicine, 1989. 9(2): p. 185-202.
3. Weissleder, R., et al., Ultrasmall Superparamagnetic Iron-Oxide - Characterization of a New Class of Contrast Agents for Mr Imaging. Radiology, 1990. 175(2): p. 489-493.
4. Wang, Y.X.J., S.M. Hussain, and G.P. Krestin, Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. European Radiology, 2001. 11(11): p. 2319-2331.
5. Weissleder, R., et al., Superparamagnetic Iron-Oxide - Pharmacokinetics and Toxicity. American Journal of Roentgenology, 1989. 152(1): p. 167-173.
6. Leamon, C.P. and P.S. Low, Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA, 1991. 88(13): p. 5572-6.
7. Reddy, J.A. and P.S. Low, Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst, 1998. 15(6): p. 587-627.
8. Weitman, S.D., et al., Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res, 1992. 52(12): p. 3396-401.
9. Ross, J.F., P.K. Chaudhuri, and M. Ratnam, Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer, 1994. 73(9): p. 2432-43.
10. Kohler, N., G.E. Fryxell, and M.Q. Zhang, A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. Journal of the American Chemical Society, 2004. 126(23): p. 7206-7211.
11. Zhang, Y., N. Kohler, and M.Q. Zhang, Surface modification of Superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials, 2002. 23(7): p. 1553-1561.
12. Zhang, Y., et al., Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomedical Microdevices, 2004. 6(1): p. 33-40.